Cellebrite DI Ltd. (NASDAQ:CLBT) Receives $13.17 Average Target Price from Analysts
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have updated their coverage on […]
More Stories
Automatic Data Processing (NASDAQ:ADP) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says
Automatic Data Processing (NASDAQ:ADP – Get Free Report) had its target price increased by analysts at Royal Bank of Canada...
Dorman Products (NASDAQ:DORM) Updates FY24 Earnings Guidance
Dorman Products (NASDAQ:DORM – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of...
Stepan (NYSE:SCL) Posts Earnings Results, Beats Estimates By $0.39 EPS
Stepan (NYSE:SCL – Get Free Report) announced its quarterly earnings data on Wednesday. The basic materials company reported $1.03 earnings...
KLA (NASDAQ:KLAC) Announces Earnings Results
KLA (NASDAQ:KLAC – Get Free Report) issued its earnings results on Wednesday. The semiconductor company reported $7.33 earnings per share...
Grove Tops 24 Hour Trading Volume of $116,435.57 (GVR)
Grove (GVR) traded down 2% against the dollar during the twenty-four hour period ending at 17:00 PM Eastern on October...
New Mountain Finance (NASDAQ:NMFC) Posts Earnings Results, Misses Expectations By $0.01 EPS
New Mountain Finance (NASDAQ:NMFC – Get Free Report) issued its earnings results on Wednesday. The company reported $0.34 earnings per...